- The folks at Hoffmann-La Roche are studying Pancreatic Cancer in individuals ages 18 years and older. This clinical trial is slated to start March 2012 and is expected to end circa March 2015.888-662-6728 (U.S. Only) Reference Study ID Number: ML23024 www.roche.com/about_roche/roche_worldwide.htm
|Recruiting||Reference Study ID Number: ML23024 email@example.com||888-662-6728 (U.S. Only)|
This study is officially titled, "Impact on Survival of Cutaneous Reactions in Erlotinib Plus Gemcitabine Treated Patients With Metastatic Pancreatic Cancer Under Conditions of Daily Routine Practice."
Germany - map
For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.